Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

27.21USD
22 Aug 2017
Change (% chg)

$0.32 (+1.19%)
Prev Close
$26.89
Open
$26.85
Day's High
$27.23
Day's Low
$26.70
Volume
1,159,703
Avg. Vol
1,481,515
52-wk High
$28.51
52-wk Low
$19.67

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $36,896.50
Shares Outstanding(Mil.): 1,372.13
Dividend: --
Yield (%): --

Financials

BRIEF-Boston Scientific Corp says entered into a $2.25 bln senior unsecured credit facility- SEC Filing

* Boston Scientific Corp - on August 4, 2017, Boston Scientific Corporation entered into a $2.25 billion senior unsecured credit facility

08 Aug 2017

UPDATE 2-Boston Scientific beats profit estimates, raises forecast

July 27 Boston Scientific Corp on Thursday reported better-than-expected quarterly profit and revenue as the U.S. medical device maker benefited from strong demand across its businesses, which also helped the company raise full-year expectations.

27 Jul 2017

Boston Scientific posts profit in second quarter

July 27 Medical device maker Boston Scientific Corp on Thursday posted a profit in the second quarter compared with a year-ago loss, helped by higher sales as well as lower litigation-related expenses.

27 Jul 2017

BRIEF-Boston Scientific outlines strategy for sustained growth at 2017 investor day

* Boston Scientific outlines strategy for sustained growth at 2017 investor day

27 Jun 2017

EXCLUSIVE: India regulator wants medical devices added to price control list, document shows

NEW DELHI/MUMBAI India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients, which if agreed could be another blow to the country's $5 billion-a-year medical-technology industry.

07 Jun 2017

Exclusive - India regulator wants medical devices added to price control list, document shows

NEW DELHI/MUMBAI India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients, which if agreed could be another blow to the country's $5 billion-a-year medical-technology industry.

07 Jun 2017

BRIEF-Boston Scientific receives CE mark for Vercise Gevia deep brain stimulation system

* Boston Scientific receives CE mark for Vercise™ Gevia™ deep brain stimulation system

06 Jun 2017

BRIEF-Boston Scientific announces positive outcomes from prospective study of bronchial thermoplasty

* Boston Scientific announces positive outcomes from prospective study of bronchial thermoplasty

24 May 2017

BRIEF-Boston Scientific announces positive results from the Reprise III clinical trial

* The Boston Scientific LOTUS™ valve system demonstrated superior efficacy to Corevalve® in global reprise III trial at one year

16 May 2017

BRIEF-Boston Scientific closes Symetis acquisition

* To immediately begin selling Acurate TA and Acurate Neo/TF valve systems in Europe and other geographies outside of U.S. Source text for Eikon: Further company coverage:

16 May 2017

Competitors

Earnings vs. Estimates